Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 878 of 5804
-
New shot could tame stubborn high cholesterol
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of SYH2053 monotherapy in patients with primary hypercholesterolemia (non-familial) or mixed dyslipidemia . This trial plans to enroll 760 Participants.
Phase: PHASE3 • Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New combo aims to tackle tough myeloma cases
Disease control Recruiting nowThe purpose of this study is to find out whether the combination of elranatamab and cyclophosphamide is an effective treatment for people with relapsed/refractory multiple myeloma (MM) who have risk factors that may affect how well their disease would respond to elranatamab alone…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug TQB6411 aims to fight advanced lung cancer
Disease control Recruiting nowTo evaluate the efficacy and safety of TQB6411 for Injection in subjects with advanced lung cancer
Phase: PHASE1, PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Zapping the brain to beat addiction: new trial tests Craving-Busting device
Symptom relief Recruiting nowThe researchers will test whether cognitively enhanced transcranial direct current stimulation (tDCS) of the dorsolateral prefrontal cortex can reduce craving in inpatients with cocaine use disorder. Neuroimaging before and after stimulation will establish the neural correlates o…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
AI spots hidden liver disease in routine scans
Diagnosis ENROLLING_BY_INVITATIONSteatotic liver disease (SLD) is one of the most prevalent chronic liver diseases worldwide, affecting nearly 30% of the global population and projected to exceed 55% by 2040. Timely identification and management of intermediate- and high-risk SLD patients are essential, yet earl…
Phase: NA • Sponsor: Shengjing Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
Shock therapy for migraines? wearable device shows promise in prevention
Disease control CompletedPreventive pharmacologic therapies for migraine aim to reduce attack frequency and duration and improve quality of life; however, their use, overall benefit and adherence are often limited. Remote electrical neuromodulation (REN) is a non-invasive FDA-cleared wearable device for …
Phase: NA • Sponsor: Theranica • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
App aims to stop anxiety and depression before they start
Prevention Not yet recruitingThe general goal is to design, develop and evaluate a personalized, self-guided and trans-diagnostic internet-based intervention to prevent anxiety and depression, based on predictive risk algorithms and decision support systems (DSS), in Spanish and Chilean adult population. Me…
Phase: NA • Sponsor: The Mediterranean Institute for the Advance of Biotechnology and Health Research • Aim: Prevention
Last updated Jun 27, 2026 07:51 UTC
-
New hope for leukemia patients: asciminib study launches in china
Disease control Recruiting nowThis is a multicenter, non-interventional real-world study designed to assess the efficacy and safety of asciminib in patients with newly diagnosed CML.The study uses a prospective data collection design to gather baseline, pre- and post-treatment, and long-term follow-up data, e…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New stroke device aims to save brain tissue by rapidly reopening arteries
Disease control Recruiting nowSUMMIT RISE Study of Acute Ischemic Stroke Patients
Phase: PHASE4 • Sponsor: Route 92 Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New drug hopes to curb rare genetic obesity
Disease control Recruiting nowThis study is researching an experimental drug called mibavademab. The study is focused on patients with a condition called monogenic obesity. Monogenic obesity is caused by a change in the leptin gene that keeps it from working properly. This causes the body to not be able to fe…
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Simple blood test could revolutionize traumatic brain injury diagnosis
Diagnosis Recruiting nowThe study is intended to cover two purposes: first, to develop a blood-based biomarker test for aiding the diagnosis of traumatic brain injury (TBI) in adult participants and for prognosis of outcome of TBI (CLIN12.1); and second, for monitoring the development of secondary event…
Sponsor: Hoffmann-La Roche • Aim: Diagnosis
Last updated Jul 01, 2026 00:00 UTC
-
Could a home urine test revolutionize STI screening for men?
Diagnosis Recruiting nowThis is a multi-center study in which the performance of the Visby Medical Men's Sexual Health Test is evaluated when run by male subjects of 14 years of age and older on self-collected first catch urine samples using the audio-visual instructions provided by the Visby App and/or…
Sponsor: Visby Medical • Aim: Diagnosis
Last updated Jul 12, 2026 00:00 UTC
-
Bringing cervical cancer screening to women with HIV: can Home-Delivered HPV tests make a difference?
Diagnosis Recruiting nowThis Clinical Trials Network for Human Immunodeficiency Virus (HIV)-Associated Cervical Cancer Screening and Treatment Optimization (CASCADE) C3001-A trial aims to assess how the introduction of a community-health-worker-facilitated model, in addition to the existing static clini…
Phase: NA • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:38 UTC
-
New drug aims to ease heavy periods caused by fibroids
Symptom relief Recruiting nowThe goal of this clinical trial was to determine whether the investigational drug KLH-2109 is effective for treating excessive menstrual bleeding in patients with uterine fibroids. Uterine fibroids are benign tumors that grown in the uterus. The primary objectives of this trial …
Phase: PHASE3 • Sponsor: JW Pharmaceutical • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
New Weight-Loss drug UBT251 enters Mid-Stage trial
Disease control Recruiting nowThe purpose of this clinical study is to find out if UBT251 is safe and effective for treating people who are living with overweight or obesity. Participants will get either UBT251 (the treatment being tested) or Placebo (a treatment that has no active medicine in it), which trea…
Phase: PHASE2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can remote doctors save stroke patients in rural hospitals?
Disease control Recruiting nowTelemedicine-supported stroke care can provide standardized guidance to hospitals and regions with limited medical resources, thereby improving treatment outcomes for stroke patients in these areas. While this approach has been widely adopted in many developed countries, its effi…
Phase: NA • Sponsor: Capital Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New shot aims to tame sickle cell pain
Disease control Recruiting nowThis is a phase 2a, global, multicenter, randomized, double-blind, placebo-controlled study investigating the safety of anumigilimab administered subcutaneously (SC) at the maximum tolerated dose (MTD) in adult participants with SCD. The primary aim of the study is to assess the…
Phase: PHASE2 • Sponsor: CSL Behring • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Could thousands of breast cancer patients skip extra radiation?
Disease control Not yet recruitingThe research hypothesis is that the tumor-free survival rate of intermediate-risk breast cancer patients exempted from RNI is not inferior to that of those receiving RNI. Patients with intermediate-risk breast cancer have a relatively low local-regional recurrence rate whether th…
Phase: PHASE3 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Wireless body sensors tested on 13,000 patients to prevent hospital deaths
Disease control Recruiting nowThe study evaluates whether implementing a wireless monitoring system for patients admitted to hospital wards reduces mortality and cardiopulmonary failure.
Phase: NA • Sponsor: King Abdullah International Medical Research Center • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Frostbite breakthrough? new drug trial aims to save limbs
Disease control Not yet recruitingSevere frostbite injury can result in significant lifelong disability and amputation. Various medicines, including intravenous vasodilators (prostaglandins/iloprost, pentoxifylline, buflomedil) along with thrombolytics (alteplase), have been described to counter tissue ischemia a…
Phase: PHASE4 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC